Navigation Links
Sanofi-aventis Reports Top-line Results from Phase III Study with Iniparib (BSI-201) in Metastatic Triple-Negative Breast Cancer
Date:1/27/2011

he United States. Patients were randomized to receive a standard chemotherapy regimen (gemcitabine and carboplatin) on days one and eight of each 21-day cycle, with or without iniparib (BSI-201) 5.6 mg/kg, which was administered on days one, four, eight and 11 of each 21-day cycle. Patients in the study had received up to two previous lines of chemotherapy in a metastatic setting. The co-primary endpoints were overall survival and progression-free survival.

About Iniparib

Iniparib (BSI-201) is a novel investigational anti-tumor agent with poly (ADP-ribose) polymerase (PARP) inhibitory activity in preclinical models. Iniparib (BSI-201) is in Phase III trials for patients with squamous non-small cell lung cancer, as well as in Phase II trials for patients with breast, lung and other cancers.

* Iniparib is the United States Adopted Name (USAN) for the investigational agent BSI-201.

About Triple-Negative Breast Cancer (TNBC)

When women are diagnosed with breast cancer, their tumors are routinely tested for the presence of estrogen and progesterone receptors and for the over-expression of HER2. However, 15 to 20 percent of all breast cancers lack over-expression of all three proteins – giving rise to the term "triple-negative breast cancer" or TNBC. Research has shown TNBC continues to be difficult to treat and associated with poorer outcomes than other types of breast cancer. Women with TNBC are not candidates for hormonal therapies such as tamoxifen or therapies targeting the human epidermal growth factor receptor 2, such as Herceptin, leaving chemotherapy as the standard treatment. Therefore, finding new strategies to enhance the effectiveness of chemotherapy in this population has become an important research focus.

About BiPar Sciences

BiPar Sciences is a biopharmaceutical organization dedicated to pioneering novel tumor-selective therapies designed to address urgent unmet ne
'/>"/>

SOURCE sanofi-aventis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
2. Sanofi-aventis Oncology Data to be Presented at San Antonio Breast Cancer Symposium
3. Sanofi-aventis Sends Letter to Genzyme Seeking Clarification on Potential Board Actions
4. Covance and sanofi-aventis Finalize Agreements for 10-year Strategic R&D Alliance
5. Sanofi-aventis to Acquire BMP Sunstone Creating a Strong Consumer Healthcare Platform in China
6. Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis
7. Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash
8. Covance and Sanofi-Aventis Sign Definitive Agreements for 10-Year Strategic R&D Alliance
9. European Hospital Anticoagulant Market Dominated by Sanofi-Aventiss Clexane
10. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
11. Sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015  HyGreen, Inc., a leader in hand hygiene monitoring, ... Medical, a subsidiary of Ascendis Health Limited, in ... year, hundreds of millions of patients around the world ... transmitted from patient to patient via the unwashed hands ...
(Date:1/23/2015)... CAPE TOWN, South Africa , Jan. 23, 2015 ... and distributor of personal protective equipment for all forms ... include the flagship Leatt-Brace® neck brace, announced today that ... minicross racing federation, now requires all riders to wear ...
(Date:1/23/2015)... Tianyin Pharmaceutical Inc. (NYSE Amex: TPI ), ... sale of patented biopharmaceutical medicine, modernized traditional Chinese medicine ... announced the business and development progress at its Jiangchuan ... the September 2014 JCM application (No. 51268) for the ...
Breaking Medicine Technology:HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4
... ROTTERDAM, The Netherlands , July 8, 2010 ... - Novel Platform Set ... , , ... monoclonal antibodies using its proprietary SIMPLE,Antibody(TM) platform, announces that it has been granted the ...
... KALAMAZOO, Mich. , July 7 Stryker Corporation (NYSE: ... 20, 2010 at 4:30 p.m., Eastern Time , to discuss the Company,s ... operational update. Operating results for the quarter ended June 30, 2010 will ... , , ...
Cached Medicine Technology:arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform 2arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform 3arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform 4Stryker to Host Conference Call on July 20, 2010 2
(Date:1/22/2015)... 2015 Blue Cross and Blue Shield of ... what it means to “Live Fearless.” , The ... share their stories about how they or someone they know ... by living in the moment. By telling these types of ...
(Date:1/22/2015)... New York (PRWEB) January 22, 2015 ... after Fresenius Medical Care recalled its GranuFlo and NaturaLyte ... multidistrict litigation underway in U.S. District Court, District of ... dated January 20th, the Court has remanded a case ...
(Date:1/22/2015)... 22, 2015 A study recently ... flagship journal Medicine & Science in Sports & ... may help reduce gastrointestinal (GI) problems associated with ... Participants in the double-blind, placebo-controlled study took 10 ...
(Date:1/22/2015)... January 22, 2015 Payday lending practices ... communities and cause financial distress to the states that ... at Howard University’s Center on Race and Wealth. , ... economic activity, payday loans at the same time substantially ...
(Date:1/22/2015)... Lower-Auto-Insurance.com has released a new blog post explaining ... for reducing the costs of an auto insurance policy . ... to get lower prices for their vehicle insurance policies. The safety ... determining policy costs. Because of this, drivers should always carry ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2
... ... in the industry with a newly redesigned newsletter and a look back on its early ... ... -- CenterWatch , a leading provider of industry news, data analysis, and proprietary market ...
... , , Case Managers ... , LITTLE ROCK, Ark., Aug. 27 The Case ... Management Model Act of 2009." Case management is a collaborative process ... health needs. , , Margaret (Peggy) Leonard, ...
... most Americans are familiar with completing a questionnaire about ... an independent panel was convened by the National Institutes ... we know and what we need to learn about ... focused on the use of family history in the ...
... Meeting of the American Political Science Association (APSA) will ... Metro Toronto Convention Centre, the InterContinental Toronto Centre, and ... time in its history that the meeting has been ... is the world,s largest gathering of political scientists; almost ...
... , LONDON, August 27 A ... living with diabetes can have a major,effect on people,s lives, ... the condition has impacted on either their ability or their,desire ... was conducted online amongst 2,000 patients with type 2,diabetes living ...
... , , DES ... that it has entered into an agreement with Pfizer Inc to ... cancer (NSCLC) tumors for the presence of gene rearrangements. Pfizer ... implicated in the progress of many cancers. To be eligible ...
Cached Medicine News:Health News:CenterWatch Celebrates 15-Year Milestone as Leading Information Provider for the Clinical Trials Industry 2Health News:CMSA Announces New Model ACT Supporting Case Management Programs 2Health News:CMSA Announces New Model ACT Supporting Case Management Programs 3Health News:Panel assesses evidence for the collection and use of family health history information 2Health News:Panel assesses evidence for the collection and use of family health history information 3Health News:105th APSA Meeting, world's largest for the study of politics, will be in Toronto Sept. 3-6 2Health News:Survey Reveals Diabetics Feel the Condition Impacts on Their Mood and Sex Life 2Health News:Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy 2Health News:Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy 3Health News:Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy 4
... The first-ever completely automatic ... that make it sophisticated yet ... a wide range of diagnostic ... without clinician intervention. This allows ...
The Guidant INSIGNIA Ultra pacing system offers sophisticated patient-specific, easy-to-use features for simplified patient management and enhanced patient safety....
The EUB-525 is a mid-size system with a full feature set. Capable of B-mode, M-mode, Doppler, Color Flow and Color Angiography it performs a variety of tasks in a simple and straightforward fashion....
... The EG-3630UR is a radial-type endoscope ... new technology gives a flicker-free, high-resolution image ... an optical system for direct visual observation. ... of performance as an endoscope as well ...
Medicine Products: